New Data to be Presented at CHEST 2021 Showcase Clinical Performance of Veracyte’s Genomic Diagnostic Tests in Lung Cancer and Interstitial Lung Disease

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--New data to be presented at CHEST 2021 will showcase performance of Veracyte's genomic diagnostic tests in lung cancer and other lung diseases

Click to view original post